Adult T cell leukemia-lymphoma (ATL) is a mature T cell malignancy associated with human T cell leukemia virus type I (HTLV-1), a retrovirus that is endemic in southwestern Japan. Because of population migration, cases of ATL are expected to increase in nonendemic areas. Here, to clarify the outcomes of patients with ATL in the nonendemic metropolitan area of Osaka, we retrospectively analyzed data from the population-based Osaka Cancer Registry from 2010 to 2015. This analysis included 91 patients age ≤70 years who received chemotherapy for ATL. With a median follow-up of 988 days in surviving patients, the probability of 2-year overall survival (OS) was 21.9% (95% confidence interval [CI], 14.1% to 30.9%) and the median OS was 9.8 months (95% CI, 7.3 to 13.5 months). The probability of 2-year OS was 22.2% in the nontransplant group (n = 63) and 21.4% in the transplant group (n = 28), without a statistically significant difference between the 2 groups. Allogeneic transplantation was not a favorable prognostic factor in patients with ATL in propensity score-adjusted analysis (P = .86, log-rank test). More clinical studies are needed to improve the clinical outcomes of patients with ATL in nonendemic areas. © 2020 American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc.
Keywords: Adult T cell leukemia-lymphoma; Allogeneic hematopoietic stem cell transplantation; Mogamulizumab.
Copyright © 2020. Published by Elsevier Inc.
Clinical impact of the CONUT score and mogamulizumab in adult T cell leukemia/lymphoma.Ann Hematol. 2019 Feb;98(2):465-471. doi: 10.1007/s00277-018-3502-7. Epub 2018 Sep 27. Ann Hematol. 2019. PMID: 30264165
A retrospective analysis of treatment outcomes in adult T cell leukemia/lymphoma patients with aggressive disease treated with or without allogeneic stem cell transplantation: A single-center experience.Biol Blood Marrow Transplant. 2015 Apr;21(4):696-700. doi: 10.1016/j.bbmt.2014.12.020. Epub 2014 Dec 24. Biol Blood Marrow Transplant. 2015. PMID: 25542158 Clinical Trial.
A case series of adult T-cell leukemia-lymphoma, associated with human T-cell leukemia virus type-1, at a single center in a non-viral-endemic metropolitan area.J Clin Exp Hematop. 2019;59(3):108-111. doi: 10.3960/jslrt.19001. J Clin Exp Hematop. 2019. PMID: 31564712 Free PMC article. Clinical Trial.
Progress in Allogeneic Hematopoietic Cell Transplantation in Adult T-Cell Leukemia-Lymphoma.Front Microbiol. 2019 Oct 1;10:2235. doi: 10.3389/fmicb.2019.02235. eCollection 2019. Front Microbiol. 2019. PMID: 31681185 Free PMC article. Review.
Friend or foe? Mogamulizumab in allogeneic hematopoietic stem cell transplantation for adult T-cell leukemia/lymphoma.Stem Cell Investig. 2016 Oct 31;3:70. doi: 10.21037/sci.2016.09.13. eCollection 2016. Stem Cell Investig. 2016. PMID: 27868052 Free PMC article. Review.